In June 2025, Pluri Biotech Ltd., a wholly owned subsidiary of the Company, and a provider of Contract Development and Manufacturing (“CDMO”) services under its PluriCDMO™ business line, entered into ...
Pluri, Inc. ("Pluri", the "Company", "we" or "us") (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions ...
Elastic , the Search AI Company, announced the general availability of Agent Builder, a complete set of capabilities that helps developers quickly build secure, reliable, context-driven AI agents. AI ...
In part two of this Industry Insights roundtable, industry leaders focus on where vendors are uniquely positioned to close ...
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
The International Society for Stem Cell Research (ISSCR) has released "Charting the Translational Pathway: ISSCR Best ...